Pacific Edge up 6% as Kaiser adopts second product
Shares of Pacific Edge jumped more than 6% after it announced healthcare giant Kaiser Permanente would begin using its Cxbladder triage product from July. Kaiser approved commercial use of Cxbladder products last June, beginning with monitor which is a regular test for those who have previously been treated for bladder cancer.
Pacific Edge up 6% as Kaiser adopts second product
Shares of Pacific Edge jumped more than 6% after it announced healthcare giant Kaiser Permanente would begin using its Cxbladder triage product from July. Kaiser approved commercial use of Cxbladder products last June, beginning with monitor which is a regular test for those who have previously been treated for bladder cancer.